Clinical Trials at Drexel Gastroenterology
The Drexel Center for Liver, Biliary and Pancreatic Diseases is running a clinical study to evaluate the effects of obeticholic acid (OCA) on improvement in nonalcoholic steatohepatitis (NASH), nonalcoholic fatty liver disease. Learn more.
Drexel Gastroenterology & Hepatology is running a clinical study evaluating the use of terlipressin for the treatment of Hepatorenal Syndrome (HRS) type 1. Learn more.
The Resolve-IT clinical trial will evaluate the efficacy of elafibranor on the resolution of nonalcoholic steatohepatitis (NASH), a form of nonalcoholic fatty liver disease. Learn more.
The information on these pages is provided for general information only and should not be used for diagnosis or treatment, or as a substitute for consultation with a physician or health care professional. If you have specific questions or concerns about your health, you should consult your health care professional.